SUPPLEMENTAL TABLES
Evaluation of compounds Sm1 -Sm44 for containing PAINS substructures, listing the three compounds found with possible promiscuous binding structure.
Compound

PAINS substructure Comments
Sm14 ene_five_het_B(90)
Methylene-thiazolone motif: a frequent hitter in biophysical assays, that can be further oxidised into a reactive metabolite, and is potentially a CYP450 covalent binder.
Sm40 catechol_A(92)
Catechol motif: associated with a risk of further oxidation into orthoquinones, potential covalent binder, especially to CYP450. 113.1 ± 3.6 105.5 ± 9.5 >100 >100 4.7 Sm44 53.5 ± 9.6 107.6 ± 10.1 >100 >100 3.8 Table S3 , related to "off target analysis" experimental procedures: Off-target activity profile of Sm4
Off-target activity profile for Sm4 at 10 µM, using Hit Profilingscreen® package from Eurofins CEREP/Panlabs (France, USA, Taiwan). 
Assay
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Compounds Preparation, related to "Compounds Preparation" experimental procedures
Marine extract library.
A library of 2688 samples of marine invertebrate and alga collected across southern Australia and Antarctica was processed to generate an extract library suitable for high throughput bioassay. EtOH extracts were decanted, concentrated, and partitioned into n-BuOH and H 2 O phases, then transferred to deep 96-well plates, resulting in a >10-fold concentration of small molecules, while removing salts. The n-BuOH fraction (25 mg/mL w/v of dried residue) was used for screening, following 10-and 100-fold dilution (2.5 and 0.25 mg/mL). Active fractions were triturated with hexane, CH 2 Cl 2 and MeOH, and fractionated into pure compounds by HPLC. All compounds were assayed in the same way as fractions.
Sm1 and Sm2.
The aqueous EtOH extract of sample of brown alga, Caulocystis cephalornithos (CMB-01671), was concentrated in vacuo (4.8 g) and partitioned into n-BuOH (0.80 g) and H2O (4.0 g) soluble materials. An aliquot (40 mg) of the n-BuOH soluble partition was subjected to HPLC fractionation (Agilent Zorbax SB C18 5 µm, 250 x 9.4 mm column, 4 mL/min gradient elution from 60% MeOH/H2O to 100% MeOH over 10 min, followed with 100% MeOH for 10 min, with isocratic 0.01% TFA modifier) to yield 6-undecyl salicylic acid (Sm1, 5.9 mg, RT 12.8 min) and 6-tridecyl salicylic acid (Sm2, 11 mg, RT 13.7 min).
Synthesis Sm15-44 -SAR library
i) SOCl 2 , reflux , 3h; Et 2 NH, CH 2 Cl 2 , 0 °C-RT, 12h; ii) s-BuLi/TMEDA, -78 °C, DMF; iii) AcOH/HCl; iv) NaH, THF, 50 °C, 2h; v) BBr 3 , CH 2 Cl 2 ; or 48% aq HBr, reflux 5 h; vi) Pd/C, H 2 atm., RT, 1h.
General Materials and Methods
Reagents and anhydrous solvents (THF, dichloromethane, and acetonitrile) were used as received. Reaction progress was monitored by TLC using Merck silica gel 60 F-254 with UV detection. Silica gel 60 (Merck 40-63 µm) was used for column chromatography. The following stain solutions have been used in addition to UV light with fluorescent TLC plates: phosphomolybdic acid, anisaldehyde/EtOH. Reactions requiring anhydrous conditions were performed under nitrogen. NMR data were collected and calibrated in d4-MeOH or CDCl 3 at 298K on a Varian Unity 400 MHz or Bruker Avance 600 MHz spectrometers. HPLC and routine mass spectra were acquired on an Agilent Technologies 1200 Series instrument, fitted with a G1316A UV-Vis detector, 1200 Series ELSD and 6110 quadrupole ESI-MS. High resolution mass spectrometry (HRMS) was performed on the Bruker MicroTOF mass spectrometer.
General procedure for preparation of N,N-diethylbenzamides (4a-d)1
The substituted N,N-diethyl benzamides were prepared from the respective substituted benzoic acids. The acid (5 g, 32.9 mmol) was refluxed with excess thionyl chloride (50 mL) until the evolution of hydrogen chloride was ceased. The excess thionyl chloride was removed under reduced pressure and co-distilled with toluene (3x15 mL). The acid chloride was dissolved in dry CH 2 Cl 2 (100 mL) and added drop wise diethylamine (13.6 mL, 131.5 mmol) at 0 o C and stirred at room temperature for overnight. The reaction mixture was diluted with CH 2 Cl 2 (100 mL), washed with water (50 mL), brine solution and dried over anhydrous MgSO 4 . The organic layer was removed on rotovapor to give the crude compound. The crude compound was purified by flash column chromatography to obtain the pure diethylbenzamide.
General procedure for directed ortho-metalation reaction (5a-d) 2 To a solution of TMEDA (0.55 mL, 3.7 mmol) in dry THF (10 mL) was added s-BuLi (2.6 mL, 3.7 mmol, 1.5 M in cyclohexane) at -78 °C and stirred for 15 min., followed by 1-methoxy-N,N-diethylbenzamide (0.35 g, 1.7 mmol) in THF (5 mL). After stirring at the same temperature for 2 h, anhydrous DMF (0.52 mL, 6.8 mmol) was added slowly. The reaction mixture was gradually warmed up to room temperature and stirred for 30 min. The reaction was quenched by addition of 6N aq. HCl solution (10 mL), and extracted with ethyl acetate (3 x 15 mL). The combined organic layers were washed with brine (10 mL), and dried over MgSO 4 . After removal of the solvent under vacuum, the residue was purified by a flash column chromatography (nhexane/ethyl acetate, 1/2) to give the product.
General procedure for cleaving N,N-diethylbenzamide (10a-d) 3 N,N-diethylbenzamide (1.3 mmol) was dissolved in glacial AcOH (3 mL), added 10% aq. HCl (3 mL), and the mixture was refluxed for 12 h. After cooling to room temperature, the acetic acid was removed under reduced pressure, diluted with H 2 O and extracted with EtOAc (30 mL). The organic layer was washed with brine, separated and dried over anhydrous MgSO 4 . The solvent was removed under reduced pressure to give the product.
General procedure for Wittig olefination reaction (12a-d) 4
To a suspension of Wittig salt (1.0 mmol) in THF (10 mL) was added t-BuOK (2.0 mmol) or NaH (2.0 mmol) at 0 o C and stirred for 30 min. The aldehyde (0.8 mmol) dissolved in THF was added slowly and stirred for overnight at room temperature (at 50 o C for reactions carried using NaH, entries 2, 4, 5, 6). The reaction was quenched with H 2 O and extracted into EtOAc (30 mL). The organic layer was washed brine (20 mL), dried over MgSO 4 , filtered, and concentrated in vacuo to give the crude compound. The crude compound was purified by flash column chromatography to obtain pure product.
General procedure for demethylation: Method A (using BBr 3 ) 5 A solution of compound (74 mg, 0.192 mmol) in CH 2 Cl 2 (70 mL) at -78 o C was treated with BBr 3 (1.0 M in CH 2 Cl 2 , 0.576 mL, 0.576 mmol). The mixture was stirred at -78 o C for 2 h, and then quenched with saturated aq. NH 4 Cl (10 mL). The mixture was allowed to warm up to room temperature and diluted with CH 2 Cl 2 (30 mL). The organic layer was washed with brine (10 mL), dried over MgSO 4 , filtered, and concentrated in vacuo.
General procedure for the demethylation: Method B (using HBr) 6 The solution of compound (100 mg, 0.192 mmol) in 48% aq. HBr (3.0 mL) was heated to reflux for 3 h. After completion of the reaction, was allowed to warm to room temperature and evaporated under reduced pressure to give crude residue. The crude compound was extracted with EtOAc (30 mL) and washed with H 2 O (20 mL). The organic layer was separated, dried (MgSO 4 ) and concentrated to give the product.
General method for reduction of olefin (14a-d)
To a solution of olefin in 1:1 (EtOAc:MeoH) was added 10% Pd/C (10 mol%) and stirred under H 2 atmosphere at room temperature for 2 h. after completion of the reaction, filtered through celite bed. The filtrate was removed under reduced pressure to afford the product.
Protein preparations, related to "Protein Preparations" experimental procedures
Mouse SOX HMG fragments.
The Full-length mouse SOX18. cDNA clone of mouse Sox18 was PCR amplified and cloned into the pOPIN-GST vector, to generate Nterminally tagged HIS-GST-SOX18. A sequence verified construct was co-transfected with flashBACULTRA (Oxford Expression Technologies, Oxford, United Kingdom) baculovirus DNA onto Spodoptera frugiperda Sf9 cells to obtain recombinantly expressed HIS-GST-SOX18. High Five cells (BTI-TN-5B1-4) in Sf-900™ II serum-free medium were infected at cell density of 1.5 x 10 6 cells/mL with a multiplicity of infection (MOI) of 5 PFU/cell, and incubated at 21°C for 144 h before harvest. The cell pellet from 100 mL of expression culture was resuspended in 30 mL of phosphate lysis buffer (50 mM sodium phosphate, 500 mM sodium chloride, 1% Triton X-100, 2 mM magnesium chloride, one tablet of cOmplete Protease Inhibitor Cocktail, pH 7.5) and sonicated on ice for 20 s. The cell lysate was centrifuged at 17,000 x g for 40 min at 4°C. Supernatant was incubated with Benzonase Nuclease (Merck Millipore) for 1 h at room temperature for DNA degradation, before being mixed with 500 µL GST resin (GE Healthcare Life Sciences, Sweden) and incubated on a rotating wheel at room temperature for 1 h. The sample was centrifuged at 500 x g for 1 min to remove unbound protein in the supernatant. The resin was further washed with 50 resin volumes (RV) wash buffer (50 mM sodium phosphate, 500 mM NaCl, pH 7.5), with unbound protein removed by centrifugation as above. Bound protein was eluted from the resin with 3 x 1 RV elution buffer (50 mM Tris, 500 mM NaCl, 10 mM reduced glutathione, pH 8.0), collecting the supernatant by centrifugation as above.
DNA-binding competition assay using fluorescence polarization (FP)
The DNA-binding competition assay was performed in 25 uL, in black 384-well plates, using either 30 mM HEPES (N-2-Hydroxyethylpiperazine-N'-2-Ethanesulfonic Acid) (pH 7.5, with 100 mM KCl, 40 mM NaCl, 10 mM NH 4 OAc, 10 mM Guanidinium, 2 mM MgCl 2 , 0.5 mM EDTA, 0.01% NP-40) for mouse full length SOX18, or Tris-NaCl (10 mM Tris pH 8.0 and 100 mM NaCl) for SOX-HMG fragments. All experiments were performed using a 40bp double-stranded Prox1-DNA element with 5' fluorescein amidite (FAM) label (Sigma Proligo or InVitrogen). Optimum binding levels were obtained at 200 nM of mouse full length SOX18 and 60 nM of SOX-HMG fragment, in presence of 5 nM labelled DNA. Controls consisted of free labelled DNA (low FP milli-Polarization index, mP), labelled DNA in presence of protein (negative control, high mP), and labelled DNA and protein in presence of 400 time competing excess of unlabelled DNA (positive control, low mP). Depending on compound, final DMSO concentrations ranged from 2 to 3.33% v/v. After mixing protein, DNA probe and compound, plates were sealed and briskly agitated in the dark for 5 minutes at room temperature, 10 minutes at 37°C, and 30 minutes at room temperature, before reading fluorescence polarization on a Tecan M1000Pro (λ exc = 485 nm, λ em = 525 nm). All experiments were performed in triplicates.
Cell-free expression and ALPHAScreen, related to corresponding main experimental procedure
Plasmid preparation and cell free-expression.
Proteins were genetically encoded with enhanced GFP (GFP), mCherry and cMyc (myc) tags, and cloned into cell free expression Gateway destination vectors: N-terminal GFP tagged (pCellFree_G03), N-terminal Cherry-cMyc (pCellFree_G07) and C-terminal Cherry-cMyc tagged (pCellFree_G08) (Gagoski et al., 2015 
ALPHAScreen.
ALPHAScreen was performed as previously described (Sierecki et al., 2014, Sierecki et al., 2013), using the cMyc detection kit and Proxiplate-384 Plus plates (PerkinElmer). The LTE lysate co-expressing the proteins of interest was diluted in buffer A (25 mM HEPES, 50 mM NaCl). For the assay, 12.5 µL (0.4 µg) of AnticMyc coated Acceptor Beads in buffer B (25 mM HEPES, 50 mM NaCl, 0.001% NP40, 0.001% casein) were aliquoted into each well. This was followed by the addition of 2 µL of diluted sample, at different concentration, and 2 µL of biotin labeled GFP-Nanotrap in buffer A. The plates were incubated for 45 min at room temperature, then adding 2 µL (0.4 µg) of streptavidin-coated Donor Beads diluted in buffer A, and incubation in the dark for 45 min at room temperature. The ALPHAScreen signal was measured on an Envision Plate Reader (PerkinElmer), using manufacturer's recommended settings (λ exc = 680/30 nm for 0.18 s, λ em = 570/100 nm after 37 ms). The resulting bell-shaped curve is an indication of a positive interaction, while a flat line reflects a lack of interaction between the proteins. The measurement of each protein pair was repeated in triplicate.
The Binding Index was calculated as:
×100.
I is the highest signal level (top of the hook effect curve) and Ineg is the lowest (background) signal level. The signals were normalized to the Iref signal obtained for the strongest interaction. The assay for disruption of protein-protein interaction (IC50) was conducted by expressing the protein pairs in LTE and incubating with a dilution range or single concentration of tested compounds (0.3 to 300 µM or 50 µM) or DMSO (0.7% DMSO final) in buffer B for 1h. Percentage of interaction was calculated as:
experiments were fitted in GraphPad Prism version 6.0 using 3-parameter non-linear regression.
Co-immunoprecipitation (Co-IP), related to corresponding main experimental procedure
Co-immunoprecipitation was performed as described previously (Sierecki et al., 2014). Briefly, SOX18-Cherry-cMyc was co-expressed with GFP-RBPJ, GFP-MEF2C or a GFP construct as negative control bait, in Leishmania tarentolae cell-free protein expression system. NaCl was added to the expressed protein (200 mM) and the samples were incubated with 10 µL of GFP-nanotrap coated beads (NHS-activated sepharose coupled with MBP-GFP-Nanotrap) for 30 min at 4 °C with gentle mixing by rotation. Subsequently, the beads were washed 6 times with 200 µL of wash buffer (PBS with 0.1% Triton X-100 and 200 mM NaCl). The proteins were released from the beads by heating for 3 min at 72 °C in 15 µL of 2x NuPAGE LDS loading buffer and resolved on NuPage Novex 4-12% gel (Life Technologies, Australia). The gel was scanned for GFP and Cherry fluorescence using a ChemiDoc MP System (Bio-Rad, Australia).
Critical micelle concentration (CMC), related to corresponding main experimental procedure
Critical micelle concentration was determined based on the incorporation of fluorescent 1,6-diphenyl-1,3,5-hexatriene (DPH) into micelles (Chattopadhyay and London, 1984). Small molecules and positive controls (neutral detergent Triton X100 and anionic detergent SDS) were cascade diluted in low binding 96-well plates from 1000 µM to 0.1 µM. Dilutions were performed in 200 mM NaCl or FP buffer. DPH was supplemented at 5 µM into black 384-well plates. Fluoresence intensity (λexc = 360 nm, λem = 430 nm) was measured following a 30-min incubation at room temperature, to graphically estimate CMC transition.
Cytotoxicity assay, related to corresponding main experimental procedure
Cell toxicity was determined using Alamar blue, as previously described (McMillian et al., 2002) . COS-7 cells were seeded as 7000 cells per well in black wall clear bottom 96-well plates in DMEM medium (Life Technologies Australia) with 10% FBS. HepG2 and HEK293 cell lines, from ATCC, were seeded as 5000 cells per well in black wall clear bottom 384-well cell culture plates in DMEM with 1% FBS. Cells were cultured for 24 h at 37 °C, 5% CO 2 . A serial dilution of compounds was added, with a final DMSO concentration adjusted to 0.5% v/v. Cells were incubated for another 24 h. 1% Triton X-100 was used as negative control, and 0.5% DMSO as positive control. 5 µM Alamar blue was added to each well and fluorescence was measured (λ exc = 560 nm, λ em = 590 nm) after 2 h incubation at 37 °C. Data were analysed using Prism software.
Direct DNA-binding assay, using surface plasmon resonance (SPR), related to corresponding main experimental procedure
Compounds were tested at a 1% v/v DMSO in HBS-EP buffer (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.005% v/v polysorbate 20, pH 7.4). The same buffer supplemented with 1% v/v DMSO was used as a mobile phase. DNA minor groove binder DAPI (4',6-diamidino-2-phenylindole), DNA intercalator and minor groove binder actinomycin D, and DNA intercalator ethidium bromide were used as positive controls. Biotinylated (one tag per probe) double strand DNA probes were prepared using a standard annealing routine (5 min at 100 °C, room temperature overnight and stored at -20 °C) of single strand anti-parallel DNA Probes purchased from Geneworks and were immobilized on CM5-SA streptavidin chips as per manufacturer's recommendations. Running buffer flow was set at 25 µL/min, cycles consisted of 4 min association, 4 min dissociation, followed with a pulse of 10 s of 10 mM Gly-HCl pH 2.5 for regeneration, and a 1 min stabilization, for compounds and actinomycin D. DAPI did not require any regeneration, whereas for ethidium bromide, a 40 s pulse at 25 µL/min of 0.5% v/v SDS was required for regeneration before stabilization. All sample and control cycles were performed in triplicate. DMSO calibration was performed as per manufacturer's recommendations. After each injection, an extra flow system wash was performed with 50% v/v DMSO to avoid carryover. Experiments were run on a Biacore T200 (GE Healthcare, USA), with one flow cell kept as a reference.
Direct protein binding assay (thermal aggregation), related to corresponding main experimental procedure
Differential static light scattering studies were conducted on a Harbinger Biotech StarGazer using mouse SOX18-HMG (109aa) in the presence and absence of either Prox1-DNA or putative small molecule ligands. An initial experiment was conducted to evaluate the compound concentration for which the change in aggregation temperature was no longer dependent on concentration. The final concentration that was used ranged from 500 µM (Sm4 and Sm14) to 1.5 mM (Sm5), depending on the necessity to limit the concentration of DMSO to 3%. A 17bp Prox1-DNA oligonucleotide was used at a final concentration of 10 µM. Binding was performed in triplicate and detected by an increase in Tagg (aggregation temperature) of > 2 °C in the presence of the ligand. Tagg was measured with the same protein batch in one single run. The reaction was carried out in Tris-NaCl buffer (10 mM Tris-HCL, 150 mM NaCl, pH 8) with 3% v/v DMSO, in a final reaction volume of 45 µl and with a mouse SOX18-HMG concentration of 154 µM. These were incubated for 1 h at room temperature before measurement. The protein was heated from 25 °C to 80 °C at a rate of 1°C per min. Total intensities were plotted against temperature for each sample, and fitted to the Boltzmann equation by non-linear regression.
In silico docking and molecular dynamics, related to corresponding main experimental procedure
Ligand-protein docking.
In silico docking of Sm4 into the SOX18/DNA complex was performed using LeadIT/FlexX (BioSolveIT, Germany). The docking was performed by removing all the water molecules from the structure of SOX18-HMG/Prox1-DNA (pdb: 4Y60) and defining the whole protein/complex as possible binding site. The best 20 docking poses of Sm4 were analysed and grouped into 4 clusters. As the SOX18/DNA does not contain a classic binding pocket, each pose cluster was further validated by a 200 ns long MD simulation. The MD simulation was performed using the full SOX18/DNA structure with Sm4 in its different binding pose. Analysis of the MD simulations revealed three of the poses as unstable, with the Sm4 breaking its interaction with the protein within the first 3 to14 ns of the simulation, remaining in the water solvent for the remaining of the simulation. Only for one of the poses the MD simulation produced a stable binding poses for Sm4 during the entire 200 ns simulation. Similarly, docking and MD simulations were performed with Sm4 and SOX18 without DNA. However, none of the 4 pose cluster produced a stable binding orientation during the MD simulation. For comparison, MD simulations were performed for SOX18/DNA and SOX18 without DNA, without Sm4, producing similar conformations and dynamic behaviour as the structures with Sm4 ligand.
Protein-protein docking.
The protein-protein docking between Notch1 transcription complex and SOX18 was performed with ClusPro online server version (cluspro.bu.edu), using pdb: 3V79 and pdb: 4Y60 for the structures of Notch1 transcription complex and SOX18-HMG, respectively. DNA molecules were removed before docking, as ClusPro is unable to process them, and restored after docking. Docking solutions with clashing DNA molecules were rejected. The resulting top docking pose was used as starting conformation in a 50 ns long MD simulation to optimize the docking pose, and validate the stability of the multi protein complex.
MD simulations.
Any MD simulation was carried using the AMBER MD software "pmemd", using the ff99SB force field for the protein and DNA, TIP3 for implicit water, and applying periodic boundary conditions (NTP), particlemesh Ewald (PME) method for long-range electrostatic interactions, isotropic pressure coupling and Langevin thermostat (gamma_ln = 1 /ps) for temperature coupling. The simulations were run with 2fs step size, constraining bonds involving hydrogens using the SHAKE algorithm. For MD simulations with Sm4, Antechamber from the AMBER package was used to calculate the force field parameter for the ligand. All MD simulations were performed by minimizing the structures and equilibrating them by reducing the position constrains slowly over 5 ns. Each simulation was done in triplicate, using different random number for the assignment of the initial velocities.
COX1/COX2 enzymatic assay
COX inhibition activity was measured using COX1 and COX2 inhibitor screening assay kits from Cayman Chemical Company (Ref# 701090 and 701080). All compounds were tested in quadruplicate at a single 200 µM concentration in 2% v/v final DMSO. Compounds were preincubated with ovine COX1 or human COX2 at 37 °C for 10 min before incubation with COX substrate arachidonic acid for another 3 min. Reactions were stopped by addition of concentrated hydrochloric acid. Prostanoid standard curve was prepared and enzyme immunoassay performed as per manufacturer's description. A DMSO control, a 100% inhibition control with heat-inactivated COX enzyme, as well as a 200 µM meclofenamate positive control (potent non-selective COX1/2 inhibitor), were included for reference. Prostanoid standards values were plotted as logit (B/B 0 ) versus log concentrations and fitted with linear regression using GraphPad Prism version 6.0. Standard curve linear fit was used to calculate each samples concentrations. Sm20   0  0  1  1  2  2  3  3  4  4  5  5  6  6  7  7  8  8  9  9  10  10   25  25  50  50  75  75  100  100  125  125  150  150  175  175  200  200 
